All in all, the anesthesia intervention effect of propofol intravenous anesthesia in patients undergoing bladder cancer resection is remarkable, with little effect on serum NGF and S100B protein levels, and does not interfere with the recovery of patients' immune function, suggesting that it can be widely used in clinical practice. The gene discussed is NGF; the disease is urinary bladder carcinoma.